Use of nitrite salts for the treatment of cardiovascular conditions

Details for Australian Patent Application No. 2004257693 (hide)

Owner The Government of the United States as represented by The Secretary of the Department of Health and Human Services

Inventors Cannon, Richard III; Schechter, Alan N.; Gladwin, Mark T.

Agent Griffith Hack

Pub. Number AU-B-2004257693

PCT Pub. Number WO2005/007173

Priority 60/485,959 09.07.03 US; 60/511,244 14.10.03 US

Filing date 9 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 23 July 2009

International Classifications

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/007173 Priority application(s): WO2005/007173

22 June 2006 Change of Name(s) of Applicant(s), Section 104

  The Government of the United States of America as represented by the Secretary, Department of Health The name of the applicant has been changed to The Government of the United States as represented by The Secretary of the Department of Health and Human Services

23 July 2009 Application Accepted

  Published as AU-B-2004257693

13 August 2009 Corrigenda

  Applications Accepted - Name Index Under the name The Government of the United States as represented by The Secretary of the Department of Health and Human Services, Application No. 2004257693, under INID (71) correct the applicant name to The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services; under INID (72) correct the co-inventor to Cannon III, Richard

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257696-Use of parthenolide derivatives as antileukemic and cytotoxic agents

2004257684-Compositions and methods for decreasing age-related deterioration in metal activities in companion animals